• Citer

The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy.

par Saussez, Sven ;Lorfevre, Francois;Lequeux, Thomas;Laurent, Guy ;Chantrain, Gilbert;Vertongen, Françoise ;Toubeau, Gérard ;Decaestecker, Christine ;Kiss, Robert
Référence Oral oncology, 44, 1, page (86-93)
Publication Publié, 2008-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy.
Auteur:	Saussez, Sven; Lorfevre, Francois; Lequeux, Thomas; Laurent, Guy; Chantrain, Gilbert; Vertongen, Françoise; Toubeau, Gérard; Decaestecker, Christine; Kiss, Robert
Informations sur la publication:	Oral oncology, 44, 1, page (86-93)
Statut de publication:	Publié, 2008-01
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	ELISA
	Galectins-1, -3, -7
	Head cancer
	Neck cancer
	Serum
MeSH keywords:	Adult
	Aged
	Aged, 80 and over
	Carcinoma, Squamous Cell -- diagnosis
	Enzyme-Linked Immunosorbent Assay
	Feasibility Studies
	Female
	Galectin 1 -- blood
	Galectin 3 -- blood
	Galectins -- blood
	Head and Neck Neoplasms -- diagnosis
	Humans
	Male
	Middle Aged
	Sensitivity and Specificity
	Tumor Markers, Biological -- blood
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:1368-8375
	info:doi/10.1016/j.oraloncology.2006.12.014
	info:pii/S1368-8375(07)00014-0
	info:scp/37049015985
	info:pmid/17350328